The 2016 CDC Opioid Guideline and Analgesic Prescribing Patterns in Older Adults With Cancer
Die CDC-Opioid-Leitlinie von 2016 und Verordnungsmuster von Analgetika bei älteren Erwachsenen mit Krebs
JAMA Network Open · 07.05.2025 · 8 (5) · e259043
DOI: 10.1001/jamanetworkopen.2025.9043 ↗Auf einen Blick
Eine Kohortenstudie fand nach Veröffentlichung der CDC-Leitlinie 2016 einen Rückgang der Opioidverordnungen bei älteren Erwachsenen mit Krebs. Gleichzeitig nahm die Verordnung von Gabapentinoiden zu.
Fragestellung
War die CDC-Leitlinie von 2016 mit veränderten Verordnungsmustern von Analgetika bei älteren Erwachsenen mit Krebs assoziiert?
Methode
Unterbrochene Zeitreihenanalyse einer longitudinalen Kohorte aus der MCBS-Datenbank (2010-2020) mit Medicare-Ansprüchen; Teilanalyse bei schlechter Prognose oder Krebs-Schmerz-Kontakt.
Ergebnisse
Die Steigung der Opioidverordnung sank nach Leitlinienveröffentlichung: typische Opioide −0,47; 95 %-KI −0,63 bis −0,30 pp/Quartal, Tramadol −0,27; 95 %-KI −0,36 bis −0,17 pp/Quartal, Buprenorphin −0,01; 95 %-KI −0,02 bis −0,01 pp/Quartal. Gabapentinoide stiegen um 24,9 %.
Schlussfolgerung der Autor:innen
In dieser Kohortenstudie war die CDC-Leitlinie 2016 mit weniger Opioidverordnungen und mehr Gabapentinoidverordnungen verbunden. Die Autoren sehen darin eine Verlagerung von Erstlinien-Opioiden zu Tramadol und Gabapentinoiden.
Kernaussagen
- Opioidverordnungen nahmen nach 2016 ab
- Gabapentinoide nahmen um 24,9 % zu
- Tramadol seltener reduziert als typische Opioide
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Leitlinie in der Zeitschrift JAMA Network Open, online erschienen am 07.05.2025. Verfasst von Rebecca Rodin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York. Hauptthemen laut MEDLINE: Analgesics, Opioid, Practice Patterns, Physicians', Cancer Pain, Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIA NIH HHS.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Importance In 2016, the Centers for Disease Control and Prevention (CDC) published guidelines cautioning against prescribing opioids for chronic noncancer pain. Little is known about unintended outcomes of this guideline on analgesic prescribing for older adults with cancer, who commonly require opioids as first-line pain treatment.
Objective
To determine whether the 2016 CDC guideline was associated with altered analgesic prescribing among older adults with cancer. Design, Setting, and Participants Interrupted time series analysis of a longitudinal cohort using Medicare Current Beneficiary Survey (MCBS) dataset (2010-2020), a nationally representative longitudinal survey of Medicare beneficiaries linked to Medicare claims. MCBS participants older than 65 years who reported a non–skin cancer diagnosis were followed up for up to 4 years. Subgroup analysis conducted for those with poor prognosis cancer or a cancer-related pain encounter (advanced cancer/cancer pain). Data were analyzed from January 2023 to February 2025. Exposure CDC Guideline for Prescribing Opioids for Chronic Pain publication in March 2016. Main Outcomes and Measures Quarterly prescribing rates of opioids (typical opioids, tramadol, and buprenorphine) and gabapentinoids (gabapentin and pregabalin). For each time series analysis outcome, a level change estimated immediate change and trend (ie, slope) change estimated ongoing change following the guideline.
Results
The cohort included 11 903 older adults with cancer (mean [IQR] age, 79.4 [73-85] years, 6504 [54.6%] women), including 1283 with advanced cancer or cancer pain. Compared with preguideline trends, we observed the following changes after the guideline release: the slope of opioid prescribing decreased (typical opioids: −0.47; 95% CI, −0.63 to −0.30 percentage points [pp]/quarter; tramadol: −0.27; 95% CI, −0.36 to −0.17 pp/quarter; buprenorphine: −0.01; 95% CI, −0.02 to −0.01 pp/quarter), though tramadol prescribing rose by 11.5% overall; and gabapentinoid prescribing increased by 24.9% (slope change, −0.03; 95% CI, −0.09 to 0.02 pp/quarter). Conclusions and Relevance In this cohort study of older adults with cancer, the 2016 CDC guideline was associated with a decline in opioid prescribing that was less pronounced for tramadol compared with typical opioids and was followed by a 25% increase in gabapentinoid prescribing. This may reflect a shift in cancer pain management from first-line opioids to tramadol, which is less safe, and gabapentinoids, which have been shown to be less effective for cancer pain treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
- Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York.
- Division of Geriatrics, Department of Medicine, University of California, San Francisco.
- Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco.
- Department of Epidemiology & Biostatistics, University of California, San Francisco.
- Division of Hematology and Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
Förderung
- NCI NIH HHS
- NIA NIH HHS
Zitieren
APA
Rodin, R., Li, L., McKendrick, K., Harrison, K., Hunt, L. J., Muench, U., Smith, C. B., Aldridge, M. D., & Morrison, R. S. (2025). The 2016 CDC Opioid Guideline and Analgesic Prescribing Patterns in Older Adults With Cancer. JAMA Network Open, 8(5), e259043. https://doi.org/10.1001/jamanetworkopen.2025.9043
Vancouver
Rodin R, Li L, McKendrick K, Harrison K, Hunt LJ, Muench U, et al. The 2016 CDC Opioid Guideline and Analgesic Prescribing Patterns in Older Adults With Cancer. JAMA Network Open. 2025;8(5):e259043. doi:10.1001/jamanetworkopen.2025.9043
BibTeX
@article{Rodin2025,
author = {Rodin, Rebecca and Li, Lihua and McKendrick, Karen and Harrison, Krista and Hunt, Lauren J and Muench, Ulrike and Smith, Cardinale B and Aldridge, Melissa D and Morrison, R Sean},
title = {The 2016 CDC Opioid Guideline and Analgesic Prescribing Patterns in Older Adults With Cancer},
journal = {JAMA Network Open},
year = {2025},
volume = {8},
number = {5},
pages = {e259043},
doi = {10.1001/jamanetworkopen.2025.9043}
}
EUVIMED